These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 21527588

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.
    Joensuu H, Wardelmann E, Sihto H, Eriksson M, Sundby Hall K, Reichardt A, Hartmann JT, Pink D, Cameron S, Hohenberger P, Al-Batran SE, Schlemmer M, Bauer S, Nilsson B, Kallio R, Junnila J, Vehtari A, Reichardt P.
    JAMA Oncol; 2017 May 01; 3(5):602-609. PubMed ID: 28334365
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
    He HY, Fang WG, Zhong HH, Li Y, Zheng J, Du J, Heng WJ, Wu BQ.
    Zhonghua Bing Li Xue Za Zhi; 2006 May 01; 35(5):262-6. PubMed ID: 16776995
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours.
    Bombac A, Zakotnik B, Bucic M, Setrajcic Dragos V, Gazic B, Stegel V, Klancar G, Novakovic S.
    Int J Oncol; 2020 Jun 01; 56(6):1468-1478. PubMed ID: 32236636
    [Abstract] [Full Text] [Related]

  • 7. KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence.
    Joensuu H, Rutkowski P, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Braconi C, Bordoni A, Magnusson MK, Sufliarsky J, Federico M, Jonasson JG, Hostein I, Bringuier PP, Emile JF.
    J Clin Oncol; 2015 Feb 20; 33(6):634-42. PubMed ID: 25605837
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
    Du CY, Shi YQ, Zhou Y, Fu H, Zhao G.
    J Surg Oncol; 2008 Sep 01; 98(3):175-8. PubMed ID: 18618605
    [Abstract] [Full Text] [Related]

  • 12. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
    Agaimy A, Terracciano LM, Dirnhofer S, Tornillo L, Foerster A, Hartmann A, Bihl MP.
    J Clin Pathol; 2009 Jul 01; 62(7):613-6. PubMed ID: 19561230
    [Abstract] [Full Text] [Related]

  • 13. Spectrum and prognostication of KIT and PDGFRA mutation in gastrointestinal stromal tumors.
    Tzen CY, Wang MN, Mau BL.
    Eur J Surg Oncol; 2008 May 01; 34(5):563-8. PubMed ID: 17532173
    [Abstract] [Full Text] [Related]

  • 14. Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors.
    Shen YY, Ma XL, Wang M, Zhuang C, Ni B, Tu L, Liu Q, Zhao WY, Cao H.
    Cancer Med; 2020 Sep 01; 9(18):6485-6496. PubMed ID: 32697050
    [Abstract] [Full Text] [Related]

  • 15. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
    Martín J, Poveda A, Llombart-Bosch A, Ramos R, López-Guerrero JA, García del Muro J, Maurel J, Calabuig S, Gutierrez A, González de Sande JL, Martínez J, De Juan A, Laínez N, Losa F, Alija V, Escudero P, Casado A, García P, Blanco R, Buesa JM, Spanish Group for Sarcoma Research.
    J Clin Oncol; 2005 Sep 01; 23(25):6190-8. PubMed ID: 16135486
    [Abstract] [Full Text] [Related]

  • 16. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
    Kalfusova A, Linke Z, Kalinova M, Krskova L, Hilska I, Szabova J, Vicha A, Kodet R.
    Pathol Res Pract; 2019 Dec 01; 215(12):152708. PubMed ID: 31708372
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
    Lasota J, Miettinen M.
    Histopathology; 2008 Sep 01; 53(3):245-66. PubMed ID: 18312355
    [Abstract] [Full Text] [Related]

  • 18. [Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors].
    Du CY, Shi YQ, Zhou Y, Fu H, Zhao GF.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul 01; 11(4):371-5. PubMed ID: 18636362
    [Abstract] [Full Text] [Related]

  • 19. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
    Miettinen M, Lasota J.
    Arch Pathol Lab Med; 2006 Oct 01; 130(10):1466-78. PubMed ID: 17090188
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.